Asensus Surgical, Inc.

NYSEAM:ASXC Stock Report

Market Cap: US$94.9m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Asensus Surgical Management

Management criteria checks 3/4

Asensus Surgical's CEO is Anthony Fernando, appointed in Nov 2019, has a tenure of 4.75 years. total yearly compensation is $2.11M, comprised of 23.7% salary and 76.3% bonuses, including company stock and options. directly owns 0.81% of the company’s shares, worth $764.99K. The average tenure of the management team and the board of directors is 2.8 years and 11.6 years respectively.

Key information

Anthony Fernando

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage23.74%
CEO tenure4.8yrs
CEO ownership0.8%
Management average tenure2.8yrs
Board average tenure11.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Anthony Fernando's remuneration changed compared to Asensus Surgical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$84m

Mar 31 2024n/an/a

-US$79m

Dec 31 2023US$2mUS$500k

-US$78m

Sep 30 2023n/an/a

-US$79m

Jun 30 2023n/an/a

-US$80m

Mar 31 2023n/an/a

-US$79m

Dec 31 2022US$2mUS$440k

-US$76m

Sep 30 2022n/an/a

-US$74m

Jun 30 2022n/an/a

-US$71m

Mar 31 2022n/an/a

-US$64m

Dec 31 2021US$7mUS$440k

-US$62m

Sep 30 2021n/an/a

-US$60m

Jun 30 2021n/an/a

-US$59m

Mar 31 2021n/an/a

-US$60m

Dec 31 2020US$3mUS$430k

-US$60m

Sep 30 2020n/an/a

-US$60m

Jun 30 2020n/an/a

-US$143m

Mar 31 2020n/an/a

-US$149m

Dec 31 2019US$2mUS$392k

-US$154m

Sep 30 2019n/an/a

-US$147m

Jun 30 2019n/an/a

-US$69m

Mar 31 2019n/an/a

-US$83m

Dec 31 2018US$2mUS$340k

-US$62m

Sep 30 2018n/an/a

-US$131m

Jun 30 2018n/an/a

-US$150m

Mar 31 2018n/an/a

-US$130m

Dec 31 2017US$1mUS$309k

-US$145m

Compensation vs Market: Anthony's total compensation ($USD2.11M) is above average for companies of similar size in the US market ($USD678.50K).

Compensation vs Earnings: Anthony's compensation has been consistent with company performance over the past year.

CEO

Anthony Fernando (52 yo)

4.8yrs
Tenure
US$2,106,498
Compensation

Mr. Anthony Fernando has been President and Chief Executive Officer and Director at Asensus Surgical, Inc. (formerly known as TransEnterix, Inc.) since November 8, 2019 and served as Chief Operating Office...

Leadership Team

NamePositionTenureCompensationOwnership
Anthony Fernando
President4.8yrsUS$2.11m0.81%
$ 765.0k
Shameze Rampertab
Executive VP & CFO4yrsUS$1.03m0.15%
$ 144.8k
Joshua Weingard
Chief Legal Officer & Secretary10.9yrsno datano data
Ethan Loiselle
Vice President of Global Marketing1.5yrsno datano data
Ravi Kommineni
Head of Global Quality & Regulatory1.5yrsno datano data
Motti Frimer
Vice President of R&Dless than a yearno datano data
2.8yrs
Average Tenure
52yo
Average Age

Experienced Management: ASXC's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Anthony Fernando
President4.8yrsUS$2.11m0.81%
$ 765.0k
William Starling
Independent Director11.6yrsUS$90.98k0.019%
$ 18.4k
Richard Pfenniger
Independent Director19.6yrsUS$101.20k0.069%
$ 65.9k
David Milne
Independent Chairman11.6yrsUS$151.98k0.23%
$ 215.7k
Steve Eubanks
Member of Advisory Boardno datano datano data
David Rattner
Member of Advisory Boardno datano datano data
Paresh Shah
Member of Advisory Boardno datano datano data
W. Melvin
Member of Advisory Boardno datano datano data
David Albala
Member of Advisory Boardno datano datano data
Jose Martinez
Member of Advisory Boardno datano datano data
Aurora Pryor
Member of Advisory Boardno datano datano data
Craig Sobolewski
Member of Advisory Boardno datano datano data
11.6yrs
Average Tenure
65.5yo
Average Age

Experienced Board: ASXC's board of directors are seasoned and experienced ( 11.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/22 06:14
End of Day Share Price 2024/08/22 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Asensus Surgical, Inc. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gregory ChodaczekB. Riley Securities, Inc.
Sean LavinBTIG
Ross OsbornCantor Fitzgerald & Co.